|
|
|
Insider
Information: |
Powell Michael |
Relationship: |
10% Owner |
City: |
San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
21 |
|
Direct
Shares |
22,645,475 |
|
Indirect Shares
|
6,181,468 |
|
|
Direct
Value |
$15,650,382 |
|
|
Indirect Value
|
$148,317,786 |
|
|
Total
Shares |
28,826,943 |
|
|
Total
Value |
$163,968,168 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
2
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
2.0
|
Percentage
Gain/Loss : |
-63.7%
|
32.1%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Seagen Inc |
SGEN |
Director |
2004-12-16 |
20,001 |
2004-12-16 |
647,577 |
Premium* |
|
Molecular Templates, Inc. |
MTEM |
Director |
2005-03-08 |
3,440,201 |
2006-03-16 |
12,846 |
Premium* |
|
Anesiva Inc |
ANSVQ |
Director, 10% Owner |
2007-12-18 |
65 |
2007-12-18 |
4,906,973 |
Premium* |
|
Paratek Pharmaceuticals Inc |
PRTK |
10% Owner |
2006-05-09 |
43,213 |
|
0 |
Premium* |
|
Orexigen Therapeutics, Inc. |
OREX |
Director |
2010-12-23 |
1 |
2010-12-23 |
0 |
Premium* |
|
Trius Therapeutics Inc |
TSRX |
Director |
2010-08-06 |
0 |
2012-03-26 |
9,302 |
Premium* |
|
Humanigen Inc |
HGEN |
10% Owner |
2013-02-05 |
414,394 |
2013-02-05 |
0 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
Director |
2016-07-29 |
0 |
2016-10-31 |
14,328 |
Premium* |
|
Aravive Inc |
ARAV |
10% Owner |
2014-03-26 |
2,146,978 |
2014-03-26 |
0 |
Premium* |
|
Hyperion Therapeutics Inc |
HPTX |
10% Owner |
2015-05-07 |
0 |
2014-06-04 |
0 |
Premium* |
|
Aerie Pharmaceuticals Inc |
AERI |
10% Owner |
2014-07-10 |
0 |
2014-07-09 |
0 |
Premium* |
|
Marinus Pharmaceuticals Inc |
MRNS |
10% Owner |
2014-08-05 |
0 |
2016-10-20 |
15,470 |
Premium* |
|
Synlogic Inc |
SYBX |
Director |
2015-10-05 |
0 |
2018-01-26 |
574,972 |
Premium* |
|
Aclaris Therapeutics, Inc. |
ACRS |
10% Owner |
2015-10-13 |
2,289,480 |
2015-10-13 |
0 |
Premium* |
|
Entasis Therapeutics Holdings Inc. |
ETTX |
10% Owner |
2018-09-28 |
1,180,178 |
2018-09-28 |
0 |
Premium* |
|
Nextcure, Inc. |
NXTC |
10% Owner |
2019-11-15 |
2,671,856 |
2019-11-15 |
0 |
Premium* |
|
Iterum Therapeutics Plc |
ITRM |
10% Owner |
2020-06-02 |
1,226,514 |
2020-06-01 |
0 |
Premium* |
|
Akouos, Inc. |
AKUS |
10% Owner |
2020-06-30 |
1,515,073 |
2020-06-30 |
0 |
Premium* |
|
Inozyme Pharma, Inc. |
INZY |
10% Owner |
2020-07-28 |
2,028,308 |
2020-07-28 |
0 |
Premium* |
|
Bolt Biotherapeutics, Inc. |
BOLT |
10% Owner |
2021-02-09 |
2,754,437 |
2021-02-09 |
0 |
Premium* |
|
Vera Therapeutics, Inc. |
VERA |
10% Owner |
2021-05-18 |
2,914,776 |
2021-05-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ANSVQ |
Anesiva Inc |
Director |
|
2007-12-18 |
4 |
B |
$4.05 |
$15,000,001 |
I/I |
3,703,704 |
3,703,704 |
2.25 |
- |
|
TSRX |
Trius Therapeutics Inc |
Director |
|
2012-01-12 |
4 |
AS |
$0.00 |
$0 |
I/I |
(3,615,572) |
28 |
0 |
- |
|
OREX |
Orexigen Therapeutics, In... |
Director |
|
2007-05-01 |
4 |
A |
$0.00 |
$0 |
I/I |
2,822,854 |
31,755 |
0 |
- |
|
TSRX |
Trius Therapeutics Inc |
Director |
|
2010-08-06 |
4 |
A |
$0.00 |
$3,913,070 |
I/I |
2,785,572 |
2,785,572 |
0 |
- |
|
MTEM |
Molecular Templates, Inc. |
Director |
|
2006-03-16 |
4 |
S |
$14.25 |
$36,508,500 |
I/I |
(2,562,000) |
12,846 |
|
- |
|
BOLT |
Bolt Biotherapeutics, Inc... |
10% Owner |
|
2021-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,304,437 |
2,304,437 |
0 |
- |
|
VERA |
Vera Therapeutics, Inc. |
10% Owner |
|
2021-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
2,187,504 |
2,187,504 |
0 |
- |
|
ARAV |
Aravive Inc |
10% Owner |
|
2014-03-26 |
4 |
A |
$0.00 |
$0 |
D/D |
2,086,978 |
2,086,978 |
0 |
- |
|
HPTX |
Hyperion Therapeutics Inc |
10% Owner |
|
2015-05-07 |
4 |
D |
$46.00 |
$89,215,804 |
D/D |
(1,939,474) |
0 |
0 |
- |
|
ACRS |
Aclaris Therapeutics, Inc... |
10% Owner |
|
2015-10-13 |
4 |
A |
$0.00 |
$0 |
D/D |
1,880,390 |
1,880,390 |
0 |
- |
|
SYBX |
Synlogic Inc |
Director |
|
2015-10-05 |
4 |
A |
$0.00 |
$0 |
I/I |
1,827,828 |
1,827,828 |
0 |
- |
|
HGEN |
Humanigen Inc |
10% Owner |
|
2013-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
1,765,117 |
31,415 |
0 |
- |
|
INZY |
Inozyme Pharma, Inc. |
10% Owner |
|
2020-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,590,808 |
1,590,808 |
0 |
- |
|
AKUS |
Akouos, Inc. |
10% Owner |
|
2020-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,456,250 |
1,456,250 |
0 |
- |
|
MRNS |
Marinus Pharmaceuticals I... |
10% Owner |
|
2014-08-05 |
4 |
A |
$0.00 |
$0 |
I/I |
1,375,166 |
15,470 |
0 |
- |
|
ANSVQ |
Anesiva Inc |
Director |
|
2005-12-15 |
4/A |
A |
$0.00 |
$0 |
I/I |
1,177,020 |
17,600 |
0 |
- |
|
ANSVQ |
Anesiva Inc |
Director |
|
2005-12-15 |
4 |
A |
$0.00 |
$0 |
I/I |
1,176,843 |
17,601 |
0 |
- |
|
AERI |
Aerie Pharmaceuticals Inc |
10% Owner |
|
2014-07-09 |
4 |
S |
$24.00 |
$24,001,300 |
D/D |
(1,000,000) |
1,566,657 |
0 |
- |
|
SYBX |
Synlogic Inc |
Director |
|
2015-10-06 |
4 |
B |
$7.00 |
$5,999,994 |
I/I |
857,142 |
2,974,811 |
2.25 |
- |
|
OCRX |
Ocera Therapeutics Inc |
Director |
|
2013-07-15 |
4 |
A |
$0.00 |
$0 |
I/I |
851,326 |
9,576 |
0 |
- |
|
OCRX |
Ocera Therapeutics Inc |
Director |
|
2016-10-31 |
4 |
D |
$0.00 |
$0 |
I/I |
(848,222) |
0 |
0 |
- |
|
TSRX |
Trius Therapeutics Inc |
Director |
|
2010-08-06 |
4 |
B |
$5.00 |
$4,150,000 |
I/I |
830,000 |
3,615,572 |
2.25 |
- |
|
ETTX |
Entasis Therapeutics Hold... |
10% Owner |
|
2018-09-28 |
4 |
A |
$0.00 |
$0 |
D/D |
817,692 |
842,454 |
0 |
- |
|
MRNS |
Marinus Pharmaceuticals I... |
10% Owner |
|
2014-08-05 |
4 |
B |
$8.00 |
$6,005,464 |
I/I |
750,683 |
27,998 |
1.5 |
- |
|
MRNS |
Marinus Pharmaceuticals I... |
10% Owner |
|
2016-10-20 |
4 |
S |
$1.39 |
$1,042,699 |
I/I |
(750,683) |
15,470 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|